Maryam Haddadzadeh Shoushtari, Hanieh Raji, S. Borsi, H. Tavakol, Bahman Cheraghian, Mahtab Moeinpour
Background: The coronavirus disease 2019 (COVID-19) pandemic has engendered scores of deaths worldwide. Just as the development of varying procedures during the pandemic has helped inhibit the disease, none is considered a definitive treatment protocol for this problem, as each induces some clinical complications pertinent to the disease. This study thus assessed the early use of sofosbuvir in outpatients with mild COVID-19. Materials and Methods: This randomized clinical trial study was conducted on 360 patients with mild COVID-19 infection at 17 Shahrivar Ahvaz Health Center. These patients were randomly divided into the intervention and control groups. Both the control and intervention groups received 400 mg of sofosbuvir and a placebo for seven days, respectively. After 14 days from the onset of the treatment, the duration of symptoms, the necessity of hospitalization, the mean of hospitalization duration, and mortality were assessed.Results: The most common symptoms in the intervention and control groups were coughs with a frequency of 46 (25.6%) and 54(30%), respectively.The two groups showed no statistically significant difference in the frequency of the first observed clinical symptom related to the disease (P=0.2). The mean days that the patients were symptomatic in the control group were 14±4.17, whereas, in the intervention group, it was 12.12±3.15 (P=0.08). The frequency of hospitalization in the control and intervention groups was 7 (3.8%) and 4 (2.22%), respectively (P=0.11). Moreover, the mean days of hospitalization in the control and the intervention groups were 4±1.1 and 3±0.8, respectively (P=0.15). In addition, the two groups had a similar frequency of hospitalization in the ICU (0) and mortality rate (0). Conclusion: Sofosbuvir alone cannot play a significant role in the treatment of outpatients with mild COVID-19.
{"title":"Evaluating the Therapeutic Effect of Sofosbuvir in Outpatients with COVID-19: A Randomized Clinical Trial Study","authors":"Maryam Haddadzadeh Shoushtari, Hanieh Raji, S. Borsi, H. Tavakol, Bahman Cheraghian, Mahtab Moeinpour","doi":"10.31661/gmj.v13i.3035","DOIUrl":"https://doi.org/10.31661/gmj.v13i.3035","url":null,"abstract":"Background: The coronavirus disease 2019 (COVID-19) pandemic has engendered scores of deaths worldwide. Just as the development of varying procedures during the pandemic has helped inhibit the disease, none is considered a definitive treatment protocol for this problem, as each induces some clinical complications pertinent to the disease. This study thus assessed the early use of sofosbuvir in outpatients with mild COVID-19. Materials and Methods: This randomized clinical trial study was conducted on 360 patients with mild COVID-19 infection at 17 Shahrivar Ahvaz Health Center. These patients were randomly divided into the intervention and control groups. Both the control and intervention groups received 400 mg of sofosbuvir and a placebo for seven days, respectively. After 14 days from the onset of the treatment, the duration of symptoms, the necessity of hospitalization, the mean of hospitalization duration, and mortality were assessed.Results: The most common symptoms in the intervention and control groups were coughs with a frequency of 46 (25.6%) and 54(30%), respectively.The two groups showed no statistically significant difference in the frequency of the first observed clinical symptom related to the disease (P=0.2). The mean days that the patients were symptomatic in the control group were 14±4.17, whereas, in the intervention group, it was 12.12±3.15 (P=0.08). The frequency of hospitalization in the control and intervention groups was 7 (3.8%) and 4 (2.22%), respectively (P=0.11). Moreover, the mean days of hospitalization in the control and the intervention groups were 4±1.1 and 3±0.8, respectively (P=0.15). In addition, the two groups had a similar frequency of hospitalization in the ICU (0) and mortality rate (0). Conclusion: Sofosbuvir alone cannot play a significant role in the treatment of outpatients with mild COVID-19.","PeriodicalId":502490,"journal":{"name":"Galen Medical Journal","volume":"6 12","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139793691","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Shabnam Rafiee, A. Hossein-Nezhad, Z. Maghbooli, A. Zargaran, S. Emamgholipour, Afsaneh Ghasemi, Mehrnoosh Ahmadi, Hadi Esmaeeli, Mehrdad Karimi
Background: Osteoporosis is a complex disease that poses major global public health challenges. Many individuals with osteoporosis turn to complementary and alternative medicine (CAM) for prevention and management. Due to its mineral contents, Padzahr, a type of clay used in traditional Persian medicine, is believed to have bone-forming properties. This study examined the impact of Padzahr on bone remodeling in postmenopausal women with low bone density.Materials and Methods: In this randomized double-blind and placebo-controlled clinical trial, 48 postmenopausal women with osteopenia were included. The participants were divided into two groups, with 24 participants in each group. One group received Padzahr, and the other group received a placebo. The participants took their assigned treatment for 12 weeks. Blood samples were taken from participants at the study’s beginning and end to compare the two groups’ serum levels of bone remodeling biomarkers.Results: At the outset of the study, the two groups were similar and there were no significant differences in any of the measured variables. Additionally, the levels of bone turnover markers were not significantly different between the two groups at the start of the study (P>0.05). After 12 weeks of treatment, the results of the ANCOVA analysis showed no significant changes in the serum levels of bone turnover indices when comparing the Padzahr group to the placebo group (P>0.05). Conclusion: A clinical trial of 3 months of Padzahr treatment in postmenopausal women with osteopenia did not show significant changes in serum markers of bone turnover.
{"title":"Effect of Padzahr Tablet on Biochemical Indices of Bone Remodeling in Postmenopausal Females with Osteopenia: A Randomized Double-Blind Placebo-Controlled Trial","authors":"Shabnam Rafiee, A. Hossein-Nezhad, Z. Maghbooli, A. Zargaran, S. Emamgholipour, Afsaneh Ghasemi, Mehrnoosh Ahmadi, Hadi Esmaeeli, Mehrdad Karimi","doi":"10.31661/gmj.v13i.2950","DOIUrl":"https://doi.org/10.31661/gmj.v13i.2950","url":null,"abstract":"Background: Osteoporosis is a complex disease that poses major global public health challenges. Many individuals with osteoporosis turn to complementary and alternative medicine (CAM) for prevention and management. Due to its mineral contents, Padzahr, a type of clay used in traditional Persian medicine, is believed to have bone-forming properties. This study examined the impact of Padzahr on bone remodeling in postmenopausal women with low bone density.Materials and Methods: In this randomized double-blind and placebo-controlled clinical trial, 48 postmenopausal women with osteopenia were included. The participants were divided into two groups, with 24 participants in each group. One group received Padzahr, and the other group received a placebo. The participants took their assigned treatment for 12 weeks. Blood samples were taken from participants at the study’s beginning and end to compare the two groups’ serum levels of bone remodeling biomarkers.Results: At the outset of the study, the two groups were similar and there were no significant differences in any of the measured variables. Additionally, the levels of bone turnover markers were not significantly different between the two groups at the start of the study (P>0.05). After 12 weeks of treatment, the results of the ANCOVA analysis showed no significant changes in the serum levels of bone turnover indices when comparing the Padzahr group to the placebo group (P>0.05). Conclusion: A clinical trial of 3 months of Padzahr treatment in postmenopausal women with osteopenia did not show significant changes in serum markers of bone turnover.","PeriodicalId":502490,"journal":{"name":"Galen Medical Journal","volume":" 17","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139792441","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Shabnam Rafiee, A. Hossein-Nezhad, Z. Maghbooli, A. Zargaran, S. Emamgholipour, Afsaneh Ghasemi, Mehrnoosh Ahmadi, Hadi Esmaeeli, Mehrdad Karimi
Background: Osteoporosis is a complex disease that poses major global public health challenges. Many individuals with osteoporosis turn to complementary and alternative medicine (CAM) for prevention and management. Due to its mineral contents, Padzahr, a type of clay used in traditional Persian medicine, is believed to have bone-forming properties. This study examined the impact of Padzahr on bone remodeling in postmenopausal women with low bone density.Materials and Methods: In this randomized double-blind and placebo-controlled clinical trial, 48 postmenopausal women with osteopenia were included. The participants were divided into two groups, with 24 participants in each group. One group received Padzahr, and the other group received a placebo. The participants took their assigned treatment for 12 weeks. Blood samples were taken from participants at the study’s beginning and end to compare the two groups’ serum levels of bone remodeling biomarkers.Results: At the outset of the study, the two groups were similar and there were no significant differences in any of the measured variables. Additionally, the levels of bone turnover markers were not significantly different between the two groups at the start of the study (P>0.05). After 12 weeks of treatment, the results of the ANCOVA analysis showed no significant changes in the serum levels of bone turnover indices when comparing the Padzahr group to the placebo group (P>0.05). Conclusion: A clinical trial of 3 months of Padzahr treatment in postmenopausal women with osteopenia did not show significant changes in serum markers of bone turnover.
{"title":"Effect of Padzahr Tablet on Biochemical Indices of Bone Remodeling in Postmenopausal Females with Osteopenia: A Randomized Double-Blind Placebo-Controlled Trial","authors":"Shabnam Rafiee, A. Hossein-Nezhad, Z. Maghbooli, A. Zargaran, S. Emamgholipour, Afsaneh Ghasemi, Mehrnoosh Ahmadi, Hadi Esmaeeli, Mehrdad Karimi","doi":"10.31661/gmj.v13i.2950","DOIUrl":"https://doi.org/10.31661/gmj.v13i.2950","url":null,"abstract":"Background: Osteoporosis is a complex disease that poses major global public health challenges. Many individuals with osteoporosis turn to complementary and alternative medicine (CAM) for prevention and management. Due to its mineral contents, Padzahr, a type of clay used in traditional Persian medicine, is believed to have bone-forming properties. This study examined the impact of Padzahr on bone remodeling in postmenopausal women with low bone density.Materials and Methods: In this randomized double-blind and placebo-controlled clinical trial, 48 postmenopausal women with osteopenia were included. The participants were divided into two groups, with 24 participants in each group. One group received Padzahr, and the other group received a placebo. The participants took their assigned treatment for 12 weeks. Blood samples were taken from participants at the study’s beginning and end to compare the two groups’ serum levels of bone remodeling biomarkers.Results: At the outset of the study, the two groups were similar and there were no significant differences in any of the measured variables. Additionally, the levels of bone turnover markers were not significantly different between the two groups at the start of the study (P>0.05). After 12 weeks of treatment, the results of the ANCOVA analysis showed no significant changes in the serum levels of bone turnover indices when comparing the Padzahr group to the placebo group (P>0.05). Conclusion: A clinical trial of 3 months of Padzahr treatment in postmenopausal women with osteopenia did not show significant changes in serum markers of bone turnover.","PeriodicalId":502490,"journal":{"name":"Galen Medical Journal","volume":"39 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139852096","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: Organizational culture plays a key role in the success of organizations. Therefore, it is important to measure the gap between stakeholders’ perceptions and expectations of the dominant culture in that organization. This study investigates the gap between the perceptions and expectations of the academic community at the Iran University of Medical Sciences.Materials and Methods: This descriptive cross-sectional study was conducted from April to the end of October 2021. 960 students, faculty members, staff, and administrators were selected using simple random sampling. The data was collected through Robbin’s organizational culture questionnaire including ten components to assess the gap between the existing (perceived) and desired (expected) organizational status.Results: The highest and lowest gap between expectations and perceptions out of five possible scores were observed in the reward system (1.74±1.16) and communication patterns (1.01±1.16) components, respectively. The gap between participants’ perceptions and expectations is associated with individuals’ demographic characteristics in most organizational culture components (P<0.05).Conclusion: Increasing productivity in the university depends on strengthening and promoting its organizational culture. The organizational culture can be improved by meeting the academic community’s expectations by paying attention to the demographic characteristics of staff and taking the necessary actions. Therefore, it should be a strategic priority for managers.
{"title":"The Gap Between Expected and Perceived Organizational Culture in an Iranian University of Medical Sciences from the Perspective of Different Stakeholder Groups","authors":"Mina Riahi, Seyed Ahmad Ahmadi, A. Aryankhesal","doi":"10.31661/gmj.v13i.2507","DOIUrl":"https://doi.org/10.31661/gmj.v13i.2507","url":null,"abstract":"Background: Organizational culture plays a key role in the success of organizations. Therefore, it is important to measure the gap between stakeholders’ perceptions and expectations of the dominant culture in that organization. This study investigates the gap between the perceptions and expectations of the academic community at the Iran University of Medical Sciences.Materials and Methods: This descriptive cross-sectional study was conducted from April to the end of October 2021. 960 students, faculty members, staff, and administrators were selected using simple random sampling. The data was collected through Robbin’s organizational culture questionnaire including ten components to assess the gap between the existing (perceived) and desired (expected) organizational status.Results: The highest and lowest gap between expectations and perceptions out of five possible scores were observed in the reward system (1.74±1.16) and communication patterns (1.01±1.16) components, respectively. The gap between participants’ perceptions and expectations is associated with individuals’ demographic characteristics in most organizational culture components (P<0.05).Conclusion: Increasing productivity in the university depends on strengthening and promoting its organizational culture. The organizational culture can be improved by meeting the academic community’s expectations by paying attention to the demographic characteristics of staff and taking the necessary actions. Therefore, it should be a strategic priority for managers.","PeriodicalId":502490,"journal":{"name":"Galen Medical Journal","volume":"262 3","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139852496","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Diabetes and related complications such as hypertension are considered major public health issues throughout the world as they are the most important causes of death and disability and cause huge economic implications for both patients and the public health system. Sufficient management of these complications along with novel patient education and self-care strategies are documented as ideal approaches able to postpone the onset of morbidity and disability and thereby delay the onset of preventable costs. However, contradictions regarding the efficacy of the studied self-care strategies are mentioned, thereby the current study aimed to review self-care strategies as a preventive approach to disease management and improving clinical outcomes in patients with diabetes and hypertension. The findings revealed that self-care through patient education with nursing support can improve medication adherence and lifestyle. However, clinical outcomes have revealed relative inconsistencies that require further studies.
{"title":"Self-Care Management, Patient Education, and Nursing Support in Patients with Diabetes and Hypertension","authors":"Amirabbas Rostami, Hamid Reza Sabet, Eftekhar Azarm, Haleh Kangari, Zahra Elihaei, Babak Khodadoustan Shahraki, Parisa Hosseini Koukamari","doi":"10.31661/gmj.v13i.3166","DOIUrl":"https://doi.org/10.31661/gmj.v13i.3166","url":null,"abstract":"Diabetes and related complications such as hypertension are considered major public health issues throughout the world as they are the most important causes of death and disability and cause huge economic implications for both patients and the public health system. Sufficient management of these complications along with novel patient education and self-care strategies are documented as ideal approaches able to postpone the onset of morbidity and disability and thereby delay the onset of preventable costs. However, contradictions regarding the efficacy of the studied self-care strategies are mentioned, thereby the current study aimed to review self-care strategies as a preventive approach to disease management and improving clinical outcomes in patients with diabetes and hypertension. The findings revealed that self-care through patient education with nursing support can improve medication adherence and lifestyle. However, clinical outcomes have revealed relative inconsistencies that require further studies.","PeriodicalId":502490,"journal":{"name":"Galen Medical Journal","volume":" 11","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139792643","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Maryam Haddadzadeh Shoushtari, Hanieh Raji, S. Borsi, H. Tavakol, Bahman Cheraghian, Mahtab Moeinpour
Background: The coronavirus disease 2019 (COVID-19) pandemic has engendered scores of deaths worldwide. Just as the development of varying procedures during the pandemic has helped inhibit the disease, none is considered a definitive treatment protocol for this problem, as each induces some clinical complications pertinent to the disease. This study thus assessed the early use of sofosbuvir in outpatients with mild COVID-19. Materials and Methods: This randomized clinical trial study was conducted on 360 patients with mild COVID-19 infection at 17 Shahrivar Ahvaz Health Center. These patients were randomly divided into the intervention and control groups. Both the control and intervention groups received 400 mg of sofosbuvir and a placebo for seven days, respectively. After 14 days from the onset of the treatment, the duration of symptoms, the necessity of hospitalization, the mean of hospitalization duration, and mortality were assessed.Results: The most common symptoms in the intervention and control groups were coughs with a frequency of 46 (25.6%) and 54(30%), respectively.The two groups showed no statistically significant difference in the frequency of the first observed clinical symptom related to the disease (P=0.2). The mean days that the patients were symptomatic in the control group were 14±4.17, whereas, in the intervention group, it was 12.12±3.15 (P=0.08). The frequency of hospitalization in the control and intervention groups was 7 (3.8%) and 4 (2.22%), respectively (P=0.11). Moreover, the mean days of hospitalization in the control and the intervention groups were 4±1.1 and 3±0.8, respectively (P=0.15). In addition, the two groups had a similar frequency of hospitalization in the ICU (0) and mortality rate (0). Conclusion: Sofosbuvir alone cannot play a significant role in the treatment of outpatients with mild COVID-19.
{"title":"Evaluating the Therapeutic Effect of Sofosbuvir in Outpatients with COVID-19: A Randomized Clinical Trial Study","authors":"Maryam Haddadzadeh Shoushtari, Hanieh Raji, S. Borsi, H. Tavakol, Bahman Cheraghian, Mahtab Moeinpour","doi":"10.31661/gmj.v13i.3035","DOIUrl":"https://doi.org/10.31661/gmj.v13i.3035","url":null,"abstract":"Background: The coronavirus disease 2019 (COVID-19) pandemic has engendered scores of deaths worldwide. Just as the development of varying procedures during the pandemic has helped inhibit the disease, none is considered a definitive treatment protocol for this problem, as each induces some clinical complications pertinent to the disease. This study thus assessed the early use of sofosbuvir in outpatients with mild COVID-19. Materials and Methods: This randomized clinical trial study was conducted on 360 patients with mild COVID-19 infection at 17 Shahrivar Ahvaz Health Center. These patients were randomly divided into the intervention and control groups. Both the control and intervention groups received 400 mg of sofosbuvir and a placebo for seven days, respectively. After 14 days from the onset of the treatment, the duration of symptoms, the necessity of hospitalization, the mean of hospitalization duration, and mortality were assessed.Results: The most common symptoms in the intervention and control groups were coughs with a frequency of 46 (25.6%) and 54(30%), respectively.The two groups showed no statistically significant difference in the frequency of the first observed clinical symptom related to the disease (P=0.2). The mean days that the patients were symptomatic in the control group were 14±4.17, whereas, in the intervention group, it was 12.12±3.15 (P=0.08). The frequency of hospitalization in the control and intervention groups was 7 (3.8%) and 4 (2.22%), respectively (P=0.11). Moreover, the mean days of hospitalization in the control and the intervention groups were 4±1.1 and 3±0.8, respectively (P=0.15). In addition, the two groups had a similar frequency of hospitalization in the ICU (0) and mortality rate (0). Conclusion: Sofosbuvir alone cannot play a significant role in the treatment of outpatients with mild COVID-19.","PeriodicalId":502490,"journal":{"name":"Galen Medical Journal","volume":"43 3-4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139853227","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: Organizational culture plays a key role in the success of organizations. Therefore, it is important to measure the gap between stakeholders’ perceptions and expectations of the dominant culture in that organization. This study investigates the gap between the perceptions and expectations of the academic community at the Iran University of Medical Sciences.Materials and Methods: This descriptive cross-sectional study was conducted from April to the end of October 2021. 960 students, faculty members, staff, and administrators were selected using simple random sampling. The data was collected through Robbin’s organizational culture questionnaire including ten components to assess the gap between the existing (perceived) and desired (expected) organizational status.Results: The highest and lowest gap between expectations and perceptions out of five possible scores were observed in the reward system (1.74±1.16) and communication patterns (1.01±1.16) components, respectively. The gap between participants’ perceptions and expectations is associated with individuals’ demographic characteristics in most organizational culture components (P<0.05).Conclusion: Increasing productivity in the university depends on strengthening and promoting its organizational culture. The organizational culture can be improved by meeting the academic community’s expectations by paying attention to the demographic characteristics of staff and taking the necessary actions. Therefore, it should be a strategic priority for managers.
{"title":"The Gap Between Expected and Perceived Organizational Culture in an Iranian University of Medical Sciences from the Perspective of Different Stakeholder Groups","authors":"Mina Riahi, Seyed Ahmad Ahmadi, A. Aryankhesal","doi":"10.31661/gmj.v13i.2507","DOIUrl":"https://doi.org/10.31661/gmj.v13i.2507","url":null,"abstract":"Background: Organizational culture plays a key role in the success of organizations. Therefore, it is important to measure the gap between stakeholders’ perceptions and expectations of the dominant culture in that organization. This study investigates the gap between the perceptions and expectations of the academic community at the Iran University of Medical Sciences.Materials and Methods: This descriptive cross-sectional study was conducted from April to the end of October 2021. 960 students, faculty members, staff, and administrators were selected using simple random sampling. The data was collected through Robbin’s organizational culture questionnaire including ten components to assess the gap between the existing (perceived) and desired (expected) organizational status.Results: The highest and lowest gap between expectations and perceptions out of five possible scores were observed in the reward system (1.74±1.16) and communication patterns (1.01±1.16) components, respectively. The gap between participants’ perceptions and expectations is associated with individuals’ demographic characteristics in most organizational culture components (P<0.05).Conclusion: Increasing productivity in the university depends on strengthening and promoting its organizational culture. The organizational culture can be improved by meeting the academic community’s expectations by paying attention to the demographic characteristics of staff and taking the necessary actions. Therefore, it should be a strategic priority for managers.","PeriodicalId":502490,"journal":{"name":"Galen Medical Journal","volume":" 14","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139792759","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Maryam Bashiri, Fatemeh Eghbalian, B. Yousefsani, S. Mahroozade
{"title":"Non-pharmacological Recommendation for Obesity Management in Persian Medicine","authors":"Maryam Bashiri, Fatemeh Eghbalian, B. Yousefsani, S. Mahroozade","doi":"10.31661/gmj.v13i.3077","DOIUrl":"https://doi.org/10.31661/gmj.v13i.3077","url":null,"abstract":"","PeriodicalId":502490,"journal":{"name":"Galen Medical Journal","volume":" 13","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139793293","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Maryam Bashiri, Fatemeh Eghbalian, B. Yousefsani, S. Mahroozade
{"title":"Non-pharmacological Recommendation for Obesity Management in Persian Medicine","authors":"Maryam Bashiri, Fatemeh Eghbalian, B. Yousefsani, S. Mahroozade","doi":"10.31661/gmj.v13i.3077","DOIUrl":"https://doi.org/10.31661/gmj.v13i.3077","url":null,"abstract":"","PeriodicalId":502490,"journal":{"name":"Galen Medical Journal","volume":"26 3","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139853291","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Diabetes and related complications such as hypertension are considered major public health issues throughout the world as they are the most important causes of death and disability and cause huge economic implications for both patients and the public health system. Sufficient management of these complications along with novel patient education and self-care strategies are documented as ideal approaches able to postpone the onset of morbidity and disability and thereby delay the onset of preventable costs. However, contradictions regarding the efficacy of the studied self-care strategies are mentioned, thereby the current study aimed to review self-care strategies as a preventive approach to disease management and improving clinical outcomes in patients with diabetes and hypertension. The findings revealed that self-care through patient education with nursing support can improve medication adherence and lifestyle. However, clinical outcomes have revealed relative inconsistencies that require further studies.
{"title":"Self-Care Management, Patient Education, and Nursing Support in Patients with Diabetes and Hypertension","authors":"Amirabbas Rostami, Hamid Reza Sabet, Eftekhar Azarm, Haleh Kangari, Zahra Elihaei, Babak Khodadoustan Shahraki, Parisa Hosseini Koukamari","doi":"10.31661/gmj.v13i.3166","DOIUrl":"https://doi.org/10.31661/gmj.v13i.3166","url":null,"abstract":"Diabetes and related complications such as hypertension are considered major public health issues throughout the world as they are the most important causes of death and disability and cause huge economic implications for both patients and the public health system. Sufficient management of these complications along with novel patient education and self-care strategies are documented as ideal approaches able to postpone the onset of morbidity and disability and thereby delay the onset of preventable costs. However, contradictions regarding the efficacy of the studied self-care strategies are mentioned, thereby the current study aimed to review self-care strategies as a preventive approach to disease management and improving clinical outcomes in patients with diabetes and hypertension. The findings revealed that self-care through patient education with nursing support can improve medication adherence and lifestyle. However, clinical outcomes have revealed relative inconsistencies that require further studies.","PeriodicalId":502490,"journal":{"name":"Galen Medical Journal","volume":"246 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-02-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139852632","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：